We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East
Monthly Production Capacity: NA
Packaging Information: 25kg/barrel
Delivery Lead Time: 10-30days
Sample Provided: yes
Payment Terms: TT; L/C;
Hypoxanthine ribonucleoside Pharmaceutical grade CAS Number 58-63-9 Molecular Formula C10H12N4O5 Molecular Weight 268.2261 EC Number 200-390-4 Package：25kg/barrel Function: treat leukopenia, thrombocytopenia, various heart diseases, acute and chronic hepatitis Application: medicine Tags: Anti Bacterial Anti Virus Enrich the blood Activating Blood Nourishing Heart.
This medicine is the normal component of the human body, it is the precursor of adenine, it can directly enter into somatic cells through the cell membrane, it involves in nucleic acid and energy metabolism, protein synthesis in body.
ITEM
STANDARD
Appearance
White crystalline Powder
Identification
Positive in No.1, 2, 3 Test
State of solution transmittance
Clear and colorless ot less then 98%
Loss on drying
=<1.0%
Heavy metals(Pb)
=<10ppm
Assay
98.0~102.0%
Residue on ignition
=<0.2%
Other Related compounds of nucleic acid
Chromatographically not detectable
Arsenic(As2O3)
=<1ppm
PH
4.8-5.8
Packing:25kg/barrel
It is applicable to a variety of reasons caused leukopenia, thrombocytopenia, various heart diseases, acute and chronic hepatitis, cirrhosis of the liver, as well as treatment of central retinitis and optic nerve atrophy.
Audited Supplier
Pharma Sources Insight JANUARY 2024
